You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨艾迪康升超7%逼近新高 機構看高目標價至20港元
格隆匯 08-18 11:09
艾迪康控股(9860.HK)逆勢拉昇升超7%,報14港元逼近上市新高,總市值超百億港元。公司是中國第三大獨立醫學實驗室(ICL),2021年市場份額佔比約為8.6%。Jefferies首次覆蓋艾迪康予“買入”評級,並給出基於PEG的目標價為20港元,較現價仍有45%左右增長空間。公司擁有380多名研發人員和1,500多名銷售人員。 該行相信,得益於其高運營效率、獨特市場定位以及持續優異業績,艾迪康將成為中國ICL行業的重要市場整合者,在2030年預計佔據15%的市場份額。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account